Alkem Labs launches lung care division Pulmocare

Mumbai-based pharma firm Alkem Laboratories has launched Pulmocare, a division to enhance awareness, diagnosis and management for lung diseases like asthma, Chronic Obstructive Pulmonary Disease (COPD), allergy, advanced lung diseases and lung infections through a wide range of products for lung care. The objective is to bring a drastic change in lung treatment accessibility in India by way of early diagnosis, better patient reach and signified health promotion. Taking the stock of filling the massive gap of accessibility of lung care for the larger populace in India, the company has decided to take a big leap to address the huge lung diseases burden in the country by launching a comprehensive lung care division.